Vaccine potential of hemocyanin from Oncomelania hupensis against Schistosoma Japonicum

Parasitology International

Volumn 60, Issue 3, 2011, Pages 242-246

  Guo, Daoyi ^a   Wang, Hua ^a   Zeng, Dan ^a   Li, Xun ^a   Fan, Xiaolin ^a   Li, Yongdong ^a  

^a GANNAN NORMAL UNIVERSITY   (China)

Author keywords

Carbohydrate epitopes; Hemocyanin; Immunization; Oncomelania hupensis; Schistosoma japonicum.; Vaccine

Indexed keywords

HEMOCYANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOLLUSC; MOUSE; NONHUMAN; ONCOMELANIA HUPENSIS; PRIORITY JOURNAL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CARBOHYDRATES; CERCARIA; EPITOPES; FEMALE; HEMOCYANIN; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SNAILS; VACCINATION; VACCINES;

ARTHROPODA; MOLLUSCA; MUS; ONCOMELANIA HUPENSIS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 79959516238     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2011.03.005     Document Type: Article

References (48)

1. van der Werf M.J., de Vlas S.J., Brooke S., Looman C.W., Nagelkerke N.J., Habbema J.D., et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003, 86:125-139.
2. Harder A. Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitol Res 2002, 88:395-397.
3. Bergquist N.R. Schistosomiasis vaccine development: progress and prospects. Mem Inst Oswaldo Cruz 1998, 93(Suppl 1):95-101.
4. Utzinger J., Zhou X.N., Chen M., GBergquist R. Conquering schistosomiasis in China: the long march. Acta Trop 2005, 96:69-96.
5. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Williams Austin C.P., Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat Med 2008, 14:407-412.
6. Cioli, Pica-Mattoccia D., Praziquantel L. Parasitol Res 2003, 90(Supp 1):S3-S9.
7. Fallon P.G., Sturrock R.F., Niang A.C., Doenhoff M.J. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 1995, 53:61-62.
8. Ismail M., Metwally A., Farghaly A., Bruce J., Tao L., F.Bennett J.L. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg 1996, 55:214-218.
9. Bergquist N.R. Schistosomiasis: from risk assessment to control. Trends Parasitol 2002, 18:309-314.
10. Pacifico L.G., Fonseca C.T., Chiari L., Oliveira S.C. Immunization with Schistosoma mansoni 22.6kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine. Immunobiology 2006, 211:97-104.
11. Pierrot C., Wilson S., Lallet H., Lafitte S., Jones F.M., Daher W., et al. Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria. Infect Immun 2006, 74:3347-3354.
12. Tran M.H., Pearson M.S., Bethony J.M., Smyth D.J., Jones M.K., Duke M., et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 2006, 12:835-840.
13. Xu X., Zhang D., Sun W., Zhang Q., Zhang J., Xue X., et al. A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens. BMC Infect Dis 2009, 9:54.
14. Minard P., Dean D.A., Jacobson R.H., Vannier W.E., Murrell K.D. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg 1978, 27:76-86.
15. Moloney N.A., Bickle Q.D., Webbe G. The induction of specific immunity against Schistosoma japonicum by exposure of mice to ultraviolet attenuated cercariae. Parasitology 1985, 90(Pt 2):313-323.
16. Ahmad G., Zhang W., Torben W., Damian R.T., Wolf R.F., White G.L., et al. Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine 2009, 27:2830-2837.
17. Siddiqui A.A., Ahmad G., Damian R.T., Kennedy R.C. Experimental vaccines in animal models for schistosomiasis. Parasitol Res 2008, 102:825-833.
18. Bergquist R., Al-Sherbiny M., Barakat R., Olds R. Blueprint for schistosomiasis vaccine development. Acta Trop 2002, 82:183-192.
19. Cummings R.D., Nyame A.K. Schistosome glysoconjugates. Biochim Biophys Acta 1999, 1455:363-374.
20. Hokke C.H., Deelder A.M. Schistosome glycoconjugates in host-parasite interplay. Glycoconj J 2001, 18:573-587.
21. Khoo K.H. Structural Variations in Schistosomal Glycans. Trends Glycoscience Glycotechnology 2001, 13:493-506.
22. Meyer S., Tefsen B., Imberty A., Geyer R., van Die I. The C-type lectin L-SIGN differentially recognizes glycan antigens on egg glycosphingolipids and soluble egg glycoproteins from Schistosoma mansoni. Glycobiology 2007, 17:1104-1119.
23. Lehr T., Geyer H., Maass K., Doenhoff M.J., Geyer R. Structural characterization of N-glycans from the freshwater snail Biomphalaria glabrata cross-reacting with Schistosoma mansoni glycoconjugates. Glycobiology 2007, 17:82-103.
24. Richter D., Incani R., NHarn D.A. Lacto-N-fucopentaose III (Lewis x), a target of the antibody response in mice vaccinated with irradiated cercariae of Schistosoma mansoni. Infect Immun 1996, 64:1826-1831.
25. Guo D., Zhang Y., Zeng D., Wang H., Li X., Li Y., et al. Functional properties of hemocyanin from Oncomelania hupensis, the intermediate host of Schistosoma japonicum. Exp Parasitol 2009, 123:277-281.
26. Pacífico L.G., Fonseca C.T., Chiari L., Oliveira S.C. Immunization with Schistosoma mansoni 22.6kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine. Immunobiology 2006, 211(1-2):97-104.
27. Idakieva K., Schwarz H., Genov N., Voelter W., Stoeva S. Rapana thomasiana hemocyanin (RtH): dissociation and reassociation behavior of two isoforms, RtH1 and RtH2. Micron 2002, 33(1):7-14.
28. Lu Z., Wang S., Peng X., Liu L., Li W., Xu S., et al. Immune reactivity between the stage-specific antigenic components from Schistosoma japonicum and the immune sera from rabbits vaccinated with irradiated cercariae. Chin J Zoonoses 2005, 21:197-201.
29. Kantelhardt S.R., Wuhrer M., Dennis R.D., Doenhoff M.J., Bickle Q., Geyer R. Fuc(alpha1->3)GalNAc-: the major antigenic motif of Schistosoma mansoni glycolipids implicated in infection sera and keyhole-limpet haemocyanin cross-reactivity. Biochem J 2002, 366:217-223.
30. Liu S., Song G., Xu Y., Yang W., McManus D.P. Immunization of mice with recombinant Sjc26GST induces a pronounced antifecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine 1995, 13(6):603-607.
31. Wilson R.A., Coulson P.S. Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Trends Parasitol 2009, 25:423-431.
32. Wuhrer M., Dennis R.D., Doenhoff M.J., Geyer R. A fucose-containing epitope is shared by keyhole limpet haemocyanin and Schistosoma mansoni glycosphingolipids. Mol Biochem Parasitol 2000, 110:237-246.
33. Thors C., Linder E. Localization and identification of Schistosoma mansoni/ KLH-crossreactive components in infected mice. J Histochem Cytochem 2003, 51:1367-1373.
34. Geyer H., Wuhrer M., Resemann A., Geyer R. Identification and characterization of keyhole limpet hemocyanin N-glycans mediating cross-reactivity with Schistosoma mansoni. J Biol Chem 2005, 280:40731-40748.
35. Mansour M.A., Ali P.O., Farid Z., Simpson A.J.G., Woody J.W. Serological differentiation of acute and chronic schistosomiasis mansoni by antibody responses to keyhole limpet hemocyanin. Am J Trop Med Hyg 1989, 41:338-344.
36. Alves-Brito C.F., Simpson A.J.G., Bahia-Oliveira L.M.G., Rabello A.L.T., Rocha R.S., Lambertucci J.R., et al. Analysis of anti-keyhole limpet haemocyanin antibody in Brazilians supports its use for the diagnosis of acute schistosomiasis mansoni. Trans R Soc Trop Med Hyg 1992, 86:53-56.
37. Li Y., Rabello A.L., Simpson A.J., Katz N. The serological differentiation of acute and chronic Schistosoma japonicum infection by ELISA using keyhole limpet haemocyanin as antigen. Trans R Soc Trop Med Hyg 1994, 88:249-251.
38. Grzych J.M., Dissous C., Capron M., Torres S., Lambert P.H., Capron A. Schistosoma mansoni shares a protective carbohydrate epitope with keyhole limpet hemocyanin. J Exp Med 1987, 165:865-878.
39. Xu S., Shi F., Shen W., Lin J., Wang Y., Ye P., et al. Vaccination of sheep against Schistosoma japonicum with either glutathione S-transferase, keyhole limpet haemocyanin or the freeze/thaw schistosomula/BCG vaccine. Vet Parasitol 1995, 58:301-312.
40. Mangold B.L., Dean D.A. The role of IgG antibodies from irradiated cercaria-immunized rabbits in the passive transfer of immunity to Schistosoma mansoni-infected mice. Am J Trop Med Hyg 1992, 47:821-829.
41. Dolashka-Angelova P., Beck A., Dolashki A., Stevanovic S., Beltramini M., Salvato B., et al. Carbohydrate moieties of molluscan Rapana venosa hemocyanin. Micron 2004, 35:101-104.
42. Dolashka-Angelova P., Lieb B., Velkova L., Heilen N., Sandra K., Nikolaeva- Glomb L., et al. Identification of glycosylated sites in Rapana hemocyanin by mass spectrometry and gene sequence, and their antiviral effect. Bioconjug Chem 2009, 20:1315-1322.
43. Wuhrer M., Robijn M.L.M., Koeleman C.A.M., Balog C.I.A., Geyer R., Deelder A.M., et al. A novel Gal(beta1-4)Gal(beta1-4)Fuc(alpha1-6)-core modification attached to the proximal N-acetylglucosamine of keyhole limpet haemocyanin (KLH) N-glycans. Biochem J 2004, 378:625-632.
44. Dolashka P., Velkova L., Shishkov S., Kostova K., Dolashki A., Dimitrov I., et al. Glycan structures and antiviral effect of the structural subunit RvH2 of Rapana hemocyanin. Carbohydr Res 2010, 345(16):2361-2367.
45. Pacífico L.G., Fonseca C.T., Barsante M.M., Cardoso L.S., Araújo M.I., Oliveira S.C. Aluminumhydroxide associated to Schistosoma mansoni 22 6 kDaprotein abrogates partial protection against experimental infection but not alter interleukin-10 production. Mem Inst Oswaldo Cruz 2006, 101(1):365-368.
46. Garcia T.C., Fonseca C.T., Pacifico L.G., Durães Fdo V., Marinho F.A., Penido M.L., et al. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice. Acta Trop 2008, 106(3):162-167.
47. Wei F., Liu Q., Gao S., Shang L., Zhai Y., Men J., et al. Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice. Vaccine 2008, 5(26(33):4145-4149.
48. Cardoso F.C., Macedo G.C., Gava E., Kitten G.T., Mati V.L., de Melo A.L., et al. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2008, 2(10):e308.